Patients Stopping Slimming Jabs Gain Back Weight Four Times Faster Than People Using Diet and Exercise

Fresh analysis indicates that people who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle programs.

Research printed in a leading medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals using these medications should be cognizant of the risk of quick rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to original mass in about one and a half years.

Comparing Approaches

The research, which examined 37 of trials involving over 9,000 of patients, compared the effects of these new drugs with older methods.

The team emphasize that individuals who lose weight through lifestyle changes alone generally experience a less rapid creep back—around 0.1 kg a month—once they finish.

The Reason for the Fast Regain

Doctors believe the way of the injections explains the heightened rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone levels far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."

An Ongoing Disease?

Medical guidelines recommend the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.

Professionals argue that, given the high risk of weight regain, the treatment is often long-term.

This view is echoed by pharmaceutical companies, who note that the results "underscore the persistent character of excess weight," similar to managing conditions like diabetes.

User Testimonies

Individuals who have stopped the jabs report a intense resurgence of cravings.

"It was like a switch flipping and you become ravenous," recalled one woman.

The struggle is exacerbated if individuals have not developed lasting dietary or behavioural modifications during treatment.

Widespread Adoption

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is greater among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

In conclusion, clinicians stress that while GLP-1 drugs are powerful agents for weight loss, they are not a magic solution and lasting health benefits relies on ongoing behavioural changes.